Capital Fund Management (CFM)
LEGN icon

Capital Fund Management (CFM)’s Legend Biotech LEGN Stock Holding History

Capital Fund Management (CFM)’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-16,495
Closed -$907K – 1553
2022
Q2 		$907K Sell
16,495
-19,940
-55% -$842K 0.01% 1107
2022
Q1 		$1.32M Buy
+36,435
New +$1.44M 0.01% 1081

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

Capital Fund Management (CFM)'s LEGN Position: Q3 2022 in Review

Capital Fund Management (CFM) sold out of Legend Biotech (LEGN) in Q3 2022, closing a stake of 16,495 shares — an estimated $907K sold.

Capital Fund Management (CFM) first reported a position in LEGN in Q1 2022 and held it in 2 quarters. The position peaked at $1.32M in Q1 2022. 159 funds tracked by Wall St. Rank hold LEGN as of Q3 2022.

  • Capital Fund Management (CFM) reported no remaining Legend Biotech position as of Q3 2022 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 16,495 Legend Biotech shares in Q3 2022, an estimated $907K.
  • Capital Fund Management (CFM) first reported a position in Legend Biotech in Q1 2022 and held it in 2 quarters.
  • Capital Fund Management (CFM)'s Legend Biotech position peaked at $1.32M in Q1 2022.
  • 159 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2022.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2022, filed 14 Nov 2022.